Health economic evaluation in Japan: A case study of one aspect of health technology assessment

Health Policy

Volumn 63, Issue 2, 2003, Pages 197-204

  Oliver, Adam ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Economic evaluation; Fee for service; Health technology assessment; Japan; Provider budgets

Indexed keywords

AGING; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; ECONOMIC DEVELOPMENT; ECONOMIC EVALUATION; HEALTH CARE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; INFANT MORTALITY; JAPAN;

BUDGETS; DELIVERY OF HEALTH CARE; FEE-FOR-SERVICE PLANS; HEALTH POLICY; HEALTH SERVICES RESEARCH; HEALTH STATUS; HUMANS; JAPAN; MOTIVATION; ORGANIZATIONAL CASE STUDIES; POLICY MAKING; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 0037305802     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8510(02)00066-0     Document Type: Article

References (27)

1. Ministry of Health Ontario Guidelines for Economic Analysis of Pharmaceutical Products. Ministry of Health, Toronto, 1994.
2. Commonwealth of Australia. Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee: Including Submissions Involving Economic Analyses. Australian Government Printing Office, Canberra, 1995.
3. Norwegian Medicines Control Authority. Norwegian Guidelines for Pharmacoeconomic Analysis in Connection with Application for Reimbursement. Norwegian Medicines Control Authority (SLK), Oslo, 1995.
4. Sickness Funds Council. Dutch Guidelines for Pharmacoeconomic Research. Ziekenfondsraad, Amstelveen, 1999.
5. National Institute of Clinical Excellence http://www.nice.org.uk, Accessed February 2002.
6. OHE HEED. Health Economic Evaluations Database. OHE-IFPMA Database Ltd., 1999.
7. Moriga M., Ikeda S., Reich M.R. An analysis of pharmacoeconomic studies in Japan. Iryo Keizai Kenkyu. 2:1995;71-81.
8. Ikeda S, Noguchi N, Oliver A. A review of pharmacoeconomic studies in Japan (abstract C27). First Annual International Meeting for the Association for Pharmacoeconomics and Outcomes Research, Philadelphia, May 12, 1996.
9. Hisashige A. Healthcare technology assessment and the challenge to pharmacoeconomics in Japan. Pharmacoeconomics. 11:(4):1997;319-333.
10. Hamashima C, Ikeda S, Yoshida K. Applicability of pharmacoeconomic studies to policy decision in Japan. Iryo to Shakai 1998; 8(1): 11-24 [In Japanese].
11. Kishimoto A. The cost-effectiveness of lifesaving interventions in Japan: Do the variations found suggest irrational resource allocation? Proceedings of the Second International Workshop on Risk Evaluation and Management of Chemicals, Yokohama, January 29, 1999.
12. Ikegami N. Personal communications, 2 March, 7 April, 4 May, 3 September, 1999.
13. Ikegami N. Health technology development in Japan. International Journal of Technology Assessment in Health Care. 4:1988;239-254.
14. Ikegami N. The economics of health care in Japan. Science. 258:1992;614-618.
15. Ikegami N., Hisashige A. Introduction. International Journal of Technology Assessment in Health Care. 10:(3):1994;341-345.
16. Ikegami N., Campbell J.C. Medical care in Japan. New England Journal of Medicine. 333:(19):1995;1295-1299.
17. Ikegami N, Campbell JC. Nihon no Iryou. Tokyo: Chuokoronsha, 1996 [In Japanese].
18. Oliver A.J., Ikegami N., Ikeda S. Japan's aging population: implications for healthcare. Pharmacoeconomics. 14:(4):1997;306-318.
19. Hisashige A., Katayama T., Mikasa H. Health economics of care for patients with cancer and intractable disease in Japan. Support Care Cancer. 6:1998;503-510.
20. Oliver A.J., Ikegami N., Ikeda S. Effect of Japanese government policy on hospital pharmaceutical profit levels. Journal of Health Services Research and Policy. 4:(1):1999;27-32.
21. Hisashige A. The introduction and evaluation of MRI in Japan. International Journal of Technology Assessment in Health Care. 10:(3):1994;392-405.
22. Ikeda S., Ikegami N., Oliver A.J., Ikeda M. A case for the adoption of pharmacoeconomic guidelines in Japan. Pharmacoeconomics. 10:(6):1996;546-551.
23. Feldman E.A. Culture, conflict, and cost: perspectives on brain death in Japan. International Journal of Technology Assessment in Health Care. 10:(3):1994;447-463.
24. Oshima A. A critical review of cancer screening programs in Japan. International Journal of Technology Assessment in Health Care. 10:(3):1994;346-358.
25. Hisashige A. Healthcare technology assessment and the challenge to pharmacoeconomics in Japan. Pharmacoeconomics. 11:(4):1997;319-333.
26. Hisashige A. The Japanese health care system at the crossroads: health care expenditures, technology utilization and gaps in health care technology assessment. Journal of Japanese Association of Radiological Technologist. 40:1993;50-64.
27. Hisashige A. Health care delivery, financing system and aging in Japan. Journal of Japanese Association of Radiological Technologist. 39:1992;27-52.